A Phase 1 Study of TE-8214 Solution in Healthy Volunteers
Status:
COMPLETED
Trial end date:
2024-12-06
Target enrollment:
Participant gender:
Summary
This is a Phase 1, first-in-human, randomized, double-blinded, placebo-controlled study to evaluate the safety, tolerability, and PK of TE-8214 in healthy volunteers. The study will assess single ascending doses (SAD) of TE-8214.